This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Dichloroacetate / DCA Metabolic Therapy

DCA is promoted as a metabolic therapy targeting pyruvate dehydrogenase kinase and the Warburg effect. Dichloroacetate has preclinical and early clinical oncology interest through metabolic targeting. It is also promoted online as an alternative cancer therapy. Human clinical use remains investigational, with neuropathy and safety issues requiring clinician oversight.

Emerging / Investigational Podcasts (2)

Jun 8, 2023

The Dr. Gundry PodcastBerberine: A Natural Alternative to Ozempic for Weight Loss?Play

The Dr. Gundry Podcast

The Dr. Gundry Podcast

Podcast episode on berberine for weight and metabolic health. Berberine: A Natural Alternative to Ozempic for Weight Loss? is a podcast_link media record from The Dr. Gundry Podcast. It is included because it discusses cancer-related diseases, protocols, people, organizations, research, prevention, treatment support, survivorship, patient experience, or practical decision-making. Review the source, date, claims, and linked records for context.

Sep 12, 2023

The Lab Report / Genova DiagnosticsBerberine: Magic Bullet or Harmful Hype?Play

The Lab Report / Genova Diagnostics

The Lab Report / Genova Diagnostics

Podcast episode discussing berberine evidence, supplement hype, and clinical cautions. This episode discusses the evidence and hype around berberine, including where it may be useful and where claims may outrun the data. It is relevant for visitors trying to separate plausible metabolic support from overstatement.
All Protocols